HuGE Literature Finder
Records
1
-
30
| Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
| Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study. Frontiers in oncology 2023 1 12 1062065. Chu Jinhua, Cai Huaju, Cai Jiaoyang, Bian Xinni, Cheng Yumei, Guan Xianmin, Chen Xiaoqian, Jiang Hua, Zhai Xiaowen, Fang Yongjun, Zhang Lei, Tian Xin, Zhou Fen, Wang Yaqin, Wang Lingzhen, Li Hong, Kwan Alex Leung Wing, Yang Minghua, Yang Hanfang, Zhan Aijun, Wang Ningling, Hu Shaoy |
| Exposure-Efficacy Analysis of Asciminib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase. Clinical pharmacology and therapeutics 2022 Jul . Combes François Pierre, Li Ying Fei, Hoch Matthias, Lorenzo Sebastien, Ho Yu-Yun, Sy Sherwin K |
| The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients. Leukemia research 2022 Mar 114 106791. Park Hyunkyung, Kang Sungbong, Kim Inho, Kim Sangsoo, Kim Hyeong-Joon, Shin Dong-Yeop, Kim Dae-Young, Lee Kyoo-Hyung, Ahn Jae-Sook, Sohn Sang-Kyun, Lee Jeong-Ok, Cheong June-Won, Kim Kyoung Ha, Kim Hoon-Gu, Kim Hawk, Lee Yoo Jin, Nam Seung-Hyun, Do Young Rok, Park Sang-Gon, Park Seong Kyu, Song Hun Ho, Jung Chul Won, Park Seonya |
| ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia. Leukemia 2022 7 36 (9): 2242-2249. Schönfeld Lioba, Rinke Jenny, Hinze Anna, Nagel Saskia N, Schäfer Vivien, Schenk Thomas, Fabisch Christian, Brümmendorf Tim H, Burchert Andreas, le Coutre Philipp, Krause Stefan W, Saussele Susanne, Safizadeh Fatemeh, Pfirrmann Markus, Hochhaus Andreas, Ernst Thom |
| BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia. Blood science (Baltimore, Md.) 2022 12 4 (4): 199-204. Zhang Yanqing, Bi Hailiang, Wang Ying, Chen Long, Pan Jiaqi, Xu Ping, Wang Wei, Yang Shaob |
| Clinical characteristics, disease evolution and survival in patients with chronic myeloid leukemia, BCR-ABL1 (+) and T315I mutation. Folia medica 2022 7 63 (5): 670-675. Goranova-Marinova Veselina, Linev Alexander, Ivanov Hristo J, Zheljazkov Ivan, Stoyanova Vily, Grudeva-Popova Zhan |
| Differences in Variants in the Structural Domain of BCR-ABL1 Kinase between Chinese Han and Minority Patients with Chronic Myeloid Leukemia by Sanger Sequencing and Next-Generation Sequencing. Cytogenetic and genome research 2022 9 162 (4): 201-206. Abulaiti Dilinazi, Tuerxun Niluopaer, Wang Huan, Abulizi Patiguli, Zhao Fang, Liu Yang, Hao Jianpi |
| Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era. Experimental hematology & oncology 2022 3 11 (1): 13. Shi Ting, Xie Mixue, Chen Li, Yuan Wei, Wang Yungui, Huang Xin, Xie Wanzhuo, Meng Haitao, Lou Yinjun, Yu Wenjuan, Tong Hongyan, Ye Xiujin, Huang Jinyan, Jin Jie, Zhu Hong |
| High Levels of Organochlorines Are Associated with Induction of ABL1 Promoter Methylation in Children with Acute Lymphoblastic Leukemia. DNA and cell biology 2022 7 41 (8): 727-734. Rafeeinia Arash, Asadikaram Gholamreza, Karimi-Darabi Mehrnaz, Moazed Vah |
| Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. Frontiers in oncology 2022 12 952640. Madejczyk Anna Marta, Canzian Federico, Góra-Tybor Joanna, Campa Daniele, Sacha Tomasz, Link-Lenczowska Dorota, Florek Izabela, Prejzner Witold, Ca?becka M, Rymko M, Dudzi?ski M, Orzechowska Magdalena Julita, Jamroziak Krzyszt |
| JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander? Hematology (Amsterdam, Netherlands) 2022 8 27 (1): 842-846. Tarantini Francesco, Cumbo Cosimo, Zagaria Antonella, Parciante Elisa, Anelli Luisa, Coccaro Nicoletta, Tota Giuseppina, Minervini Crescenzio Francesco, Redavid Immacolata, Rossi Antonella Russo, Conserva Maria Rosa, Specchia Giorgina, Musto Pellegrino, Albano Frances |
| Long-Term Molecular Remission after Treatment with Imatinib in a Chronic Myeloid Leukemia Patient with Extreme Thrombocytosis Harboring Rare e14a3 (b3a3) BCR::ABL1 Transcript: A Case Report. Current oncology (Toronto, Ont.) 2022 11 29 (11): 8171-8179. Zhang Xupai, Sun Haoping, Su Yi, Yi H |
| Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia. EJHaem 2022 12 3 (4): 1145-1153. Ahn Jae-Sook, Kim TaeHyung, Jung Sung-Hoon, Ahn Seo-Yeon, Song Ga-Young, Kim Mihee, Yang Deok-Hwan, Lee Je-Jung, Kim Mi Yeon, Moon Joon Ho, Zhang Zhaolei, Kim Hyeoung-Joon, Kim Dennis Dong Hw |
| Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia. Blood cancer journal 2022 10 12 (10): 144. Bidikian Aram, Kantarjian Hagop, Jabbour Elias, Short Nicholas J, Patel Keyur, Ravandi Farhad, Sasaki Koji, Issa Ghayas |
| Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients. Leukemia research 2021 Oct 111 106728. Park Hyunkyung, Kim Inho, Kim Hyeong-Joon, Shin Dong-Yeop, Lee Sung-Yeoun, Kwon Oh-Hyung, Kim Dae-Young, Lee Kyoo-Hyung, Ahn Jae-Sook, Park Jinny, Sohn Sang-Kyun, Lee Jeong-Ok, Cheong June-Won, Kim Kyoung Ha, Kim Hoon-Gu, Kim Hawk, Lee Yoo Jin, Nam Seung-Hyun, Do Young Rok, Park Sang-Gon, Park Seong Kyu, Bae Sung Hwa, Song Hun Ho, Oh Doyeun, Jung Chul Won, Park Seonya |
| Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study. Genes, chromosomes & cancer 2021 Jan . Orsmark-Pietras Christina, Landberg Niklas, Lorenz Fryderyk, Uggla Bertil, Höglund Martin, Lehmann Sören, Derolf Åsa, Deneberg Stefan, Antunovic Petar, Cammenga Jörg, Möllgård Lars, Wennström Lovisa, Lilljebjörn Henrik, Rissler Marianne, Fioretos Thoas, Lazarevic Vladimir |
| Glutathione S-transferase gene polymorphic sequence variations: Association with risk and response to Imatinib among Chronic Myeloid Leukemia patients of Kashmir. International journal of laboratory hematology 2021 Jan . Baba Shahid M, Shah Zafar A, Pandith Arshad A, Geelani Sajad A, Mir Mohammad M, Bhat Javid R, Gul Ayaz, Bhat Gul |
| BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib. Leukemia & lymphoma 2021 1 62 (6): 1528-1531. Benjamin Esther Sathya Bama, Ravindra Niveditha, Rajamani Bharathi Murugan, Anandan Senthamizhselvi, Kausalya Bagavathi, Veldore Vidya, Mathews Vikram, Velayudhan Shaji Ramachandran, Balasubramanian Poonkuzha |
| Clinical and Molecular Attributes of Patients With BCR/ABL1-negative Myeloproliferative Neoplasms in India: Real-world Data and Challenges. Clinical lymphoma, myeloma & leukemia 2021 3 21 (6): e569-e578. Singh Suvir, Kaur Komalpreet, Paul Davinder, Jain Kunal, Singh Jagdeep, Narang Vikram, Garg Bhavna, Sood Neena, Dhillon Barjinderj |
| Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors. Gene 2021 12 813 146101. Ismail Mohamed A, Nasrallah Gheyath K, Monne Maria, AlSayab Ali, Yassin Mohamed A, Varadharaj Govindarajulu, Younes Salma, Sorio Claudio, Cook Richard, Modjtahedi Helmout, Al-Dewik Nader |
| Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials. Haematologica 2021 11 107 (9): 2051-2063. Creasey Thomas, Barretta Emilio, Ryan Sarra L, Butler Ellie, Kirkwood Amy A, Leongamornlert Daniel, Papaemmanuil Elli, Patrick Pip, Clifton-Hadley Laura, Patel Bela, Menne Tobias, McMillan Andrew K, Harrison Christine J, Rowntree Clare J, Morley Nick, Marks David I, Fielding Adele K, Moorman Anthony |
| Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update. Frontiers in genetics 2021 8 12 697009. Zhang Heyang, Liu Meng, Wang Xiaoxue, Ren Yuan, Kim Young Mi, Wang Xianfu, Lu Xianglan, Pang Hui, Liu Guangming, Gu Yue, Sun Mingran, Shi Yunpeng, Zhang Chuan, Zhang Yaowen, Zhang Jianqin, Li Shibo, Zhang Lij |
| Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype. Acta oncologica (Stockholm, Sweden) 2021 3 60 (6): 760-770. Hrabovsky Stepan, Vrzalova Zuzana, Stika Jiri, Jelinkova Hana, Jarosova Marie, Navrkalova Veronika, Martenek Jiri, Folber Frantisek, Salek Cyril, Horacek Jan M, Pospisilova Sarka, Mayer Jiri, Doubek Micha |
| IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial. Blood advances 2021 9 5 (17): 3322-3332. Mitchell Rachel J, Kirkwood Amy A, Barretta Emilio, Clifton-Hadley Laura, Lawrie Emma, Lee SooWah, Leongamornlert Daniel, Marks David I, McMillan Andrew K, Menne Tobias F, Papaemmanuil Elli, Patel Bela, Patrick Pip, Rowntree Clare J, Zareian Nahid, Alapi Krisztina Zuborne, Moorman Anthony V, Fielding Adele |
| Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? Mediterranean journal of hematology and infectious diseases 2021 11 13 (1): e2021062. Sora Federica, Chiusolo Patrizia, Autore Francesco, Giammarco Sabrina, Laurenti Luca, Innocenti Idanna, Metafuni Elisabetta, Galli Eugenio, Bacigalupo Andrea, Sica Simo |
| KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia. ImmunoHorizons 2021 8 5 (8): 687-702. Izumi Kiyotaka, Shindo Takero, Ngo Huong Thi, Nakayama-Hosoya Kaori, Akahane Koshi, Tamai Minori, Nguyen Thao T T, Kawana-Tachikawa Ai, Inukai Takeshi, Takaori-Kondo Akifu |
| Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL. Blood 2021 4 138 (11): 948-958. Paietta Elisabeth, Roberts Kathryn G, Wang Victoria, Gu Zhaohui, Buck Georgina A N, Pei Deqing, Cheng Cheng, Levine Ross L, Abdel-Wahab Omar, Cheng Zhongshan, Wu Gang, Qu Chunxu, Shi Lei, Pounds Stanley, Willman Cheryl L, Harvey Richard, Racevskis Janis, Barinka Jan, Zhang Yanming, Dewald Gordon W, Ketterling Rhett P, Alejos David, Lazarus Hillard M, Luger Selina M, Foroni Letizia, Patel Bela, Fielding Adele K, Melnick Ari, Marks David I, Moorman Anthony V, Wiernik Peter H, Rowe Jacob M, Tallman Martin S, Goldstone Anthony H, Mullighan Charles G, Litzow Mark |
| VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer. BMC medical genomics 2021 5 14 (1): 121. Kim Min-Hye, Yang Gi-Eun, Jeong Mi-So, Mun Jeong-Yeon, Lee Sang-Yeop, Nam Jong-Kil, Choi Yung Hyun, Kim Tae Nam, Leem Sun-H |
| [Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways]. Terapevticheskii arkhiv 2020 12 92 (7): 31-42. Zarubina K I, Parovichnikova E N, Surin V L, Pshenichnikova O S, Gavrilina O A, Isinova G A, Troitskaia V V, Sokolov A N, Gal'tseva I V, Kapranov N M, Davydova I O, Obukhova T N, Sudarikov A B, Savchenko V |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: